This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
Home
Products

Products

GB only content
admelog logo
Admelog®
Learn more

MAT-XU-2302443 (v3.0) Date of Preparation: October 2023   

Aldurazyme® (laronidase)
Aldurazyme®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-XU-2200954 (v5.0) Date of Preparation: December 2023  

Aubagio® (teriflunomide)
Aubagio®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-XU-2200676 (v6.0) Date of preparation: October 2023  

AVAXIM® (hepatitis A vaccine (inactivated, adsorbed))
Avaxim®
Learn more
Prescribing Information UK

MAT-XU-2301117 (v2.0) Date of preparation: October 2023  

Avaxim® Junior (hepatitis A vaccine (inactivated, adsorbed))
Avaxim® Junior
Learn more
Prescribing Information UK

MAT-XU-2301296 (v3.0) Date of preparation: October 2023  

Cerdelga®▼ (hard capsules eliglustat)
Cerdelga®▼
Learn more
Prescribing Information GB
Prescribing Information IE

MAT-XU-2204064 (v3.0) Date of preparation: October 2023  

Cerezyme® (imiglucerase for injection)
Cerezyme®
Learn more
Prescribing Information GB
Prescribing Information IE

MAT-XU-2204065 (v3.0) Date of preparation: October 2023  

Clexane (enoxaparin)
Clexane®
Learn more
Prescribing Information UK

MAT-XU-2204397 (v4.0) Date of Preparation: October 2023  

Logo dupixent
Dupixent® (dupilumab) Atopic Dermatitis
Learn more
Prescribing Information GB
Prescribing Information NI & RoI

MAT-XU-2304409 (v2.0) Date of Preparation April 2024  

Logo dupixent
Dupixent® (dupilumab) Prurigo Nodularis
Learn more
Prescribing Information GB
Prescribing Information NI & RoI

MAT-XU-2400765 (v2.0) Date of Preparation April 2024  

Fabrazyme® (agalsidase beta)
Fabrazyme®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-GB-2105812 (v6.0) Date of preparation: March 2024  

Lantus® (insulin glargine 100 units/mL)
Lantus®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-XU-2201444 (v4.0) Date of Preparation: October 2023  

Lemtrada® (alemtuzumab)
Lemtrada®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v3.0) Date of Preparation: December 2023  

GB only content
MenQuadfiTM▼  (meningococcal (group A,C,W,Y) conjugate vaccine)
MenQuadfiTM▼ 
Learn more
Prescribing Information GB

MAT-XU-2400154 (v1.0) Date of preparation: February 2024  

Myozyme® (alglucosidase alfa)
Myozyme®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-XU-2302935 (v1.0) Date of preparation: October 2023  

GB only content
Nexviadyme Logo
Nexviadyme®▼
Learn more
Prescribing Information GB

MAT-XU-2203480 (v10.0) Date of preparation: March 2024  

Praluent® (alirocumab)
Praluent®
Learn more
Prescribing Information (GB)
Prescribing Information (NI)

MAT-XU-2204604 (v4.0) Date of Preparation: October 2023  

Quadrivalent Influenza Vaccine (split virion, inactivated)
Quadrivalent Influenza Vaccine
Learn more
Prescribing Information UK

MAT-XU-2301127 (v2.0) Date of preparation: October 2023  

Repevax® (diphtheria, tetanus, pertussis and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Repevax®
Learn more
Prescribing Information UK

MAT-XU-2301125 (v3.0) Date of preparation: October 2023  

Revaxis® diphtheria, tetanus & poliomyelitis (inactivated) vaccine (absorbed, reduced antigen(s) content)
Revaxis® 
Learn more
Prescribing Information UK

MAT-XU-2301123 (v2.0) Date of preparation: October 2023  

GB only content
rezurock logo
Rezurock®▼
Learn more

MAT-XU-2305107 (v2.0) Date of Preparation: March 2024  

GB only content
Sarclisa Logo
SARCLISA®▼
Learn more
Prescribing Information GB

MAT-XU-2202578 (v3.0) Date of preparation: December 2023  

Stamaril® (yellow fever vaccine (live))
Stamaril®
Learn more
Prescribing Information UK

MAT-XU-2301130 (v2.0) Date of preparation: October 2023  

GB only content
Supemtek▼ (quadrivalent Influenza Vaccine (recombinant, prepared in cell culture))
Supemtek▼
Learn more
Prescribing Information GB

MAT-XU-2301126 (v2.0) Date of preparation: December 2023  

Toujeo® (insulin glargine 300 units/ml)
Toujeo®
Learn more
Prescribing Information GB
Prescribing Information NI

MAT-XU-2302426 (v10.0) Date of Preparation: March 2024  

GB only content
Trurapi logo
Trurapi®▼
Learn more

MAT-XU-2205461 (v9.0)  Date of Preparation: February 2024  

Typhim Vi® (typhoid polysaccharide vaccine)
Typhim Vi®
Learn more
Prescribing Information UK

MAT-XU-2301128 (v2.0) Date of preparation: October 2023  

GB only content
Vaxelis®
Learn more
Prescribing Information GB

MAT-XU-2301124 (v4.0) Date of preparation: April 2024  

Verorab®
Learn more
Prescribing Information (GB)
Prescribing Information (NI)

MAT-XU-2400750 (v1.0) | March 2024  

Viatim®
Learn more
Prescribing Information UK

MAT-XU-2305576(v1.0) Date of preparation: December 2023  

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023